IRIS
CARRIERI, Antonio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.878
AS - Asia 3.515
EU - Europa 3.480
SA - Sud America 841
AF - Africa 126
OC - Oceania 8
Totale 17.848
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.731
SG - Singapore 1.396
IT - Italia 1.040
CN - Cina 805
BR - Brasile 685
DE - Germania 546
SE - Svezia 407
HK - Hong Kong 393
RU - Federazione Russa 344
VN - Vietnam 303
FR - Francia 289
GB - Regno Unito 225
UA - Ucraina 171
FI - Finlandia 141
IN - India 122
BD - Bangladesh 114
ID - Indonesia 65
CA - Canada 64
TR - Turchia 57
AR - Argentina 49
MX - Messico 42
IE - Irlanda 40
NL - Olanda 39
JP - Giappone 38
IQ - Iraq 37
PL - Polonia 36
CI - Costa d'Avorio 35
BE - Belgio 34
AT - Austria 27
CO - Colombia 27
ES - Italia 24
ZA - Sudafrica 24
IR - Iran 22
PK - Pakistan 21
CH - Svizzera 20
EC - Ecuador 19
SA - Arabia Saudita 19
VE - Venezuela 17
CZ - Repubblica Ceca 16
PH - Filippine 16
UZ - Uzbekistan 16
CL - Cile 14
LT - Lituania 14
MY - Malesia 13
EG - Egitto 11
JO - Giordania 11
MA - Marocco 11
JM - Giamaica 10
KE - Kenya 9
PY - Paraguay 9
CR - Costa Rica 8
DK - Danimarca 8
DZ - Algeria 7
TN - Tunisia 7
UY - Uruguay 7
AE - Emirati Arabi Uniti 6
AL - Albania 6
AU - Australia 6
AZ - Azerbaigian 6
DO - Repubblica Dominicana 6
EE - Estonia 6
KR - Corea 6
PE - Perù 6
RO - Romania 6
TH - Thailandia 6
BO - Bolivia 5
KG - Kirghizistan 5
OM - Oman 5
RS - Serbia 5
BY - Bielorussia 4
GA - Gabon 4
GE - Georgia 4
LB - Libano 4
NG - Nigeria 4
NO - Norvegia 4
NP - Nepal 4
PT - Portogallo 4
TW - Taiwan 4
BA - Bosnia-Erzegovina 3
HU - Ungheria 3
IL - Israele 3
LY - Libia 3
TT - Trinidad e Tobago 3
AO - Angola 2
BB - Barbados 2
BG - Bulgaria 2
BH - Bahrain 2
ET - Etiopia 2
GR - Grecia 2
GY - Guiana 2
HN - Honduras 2
HR - Croazia 2
IS - Islanda 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
MD - Moldavia 2
MK - Macedonia 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
SK - Slovacchia (Repubblica Slovacca) 2
Totale 17.820
Salva come PNG Salva come JPEG
Città #
Dallas 2.468
Ashburn 731
Singapore 731
Fairfield 725
Woodbridge 506
Chandler 505
San Jose 465
Houston 396
Hong Kong 378
Jacksonville 356
Milan 335
Nyköping 298
Seattle 288
Cambridge 251
Wilmington 239
Ann Arbor 222
Beijing 187
Bari 167
Lauterbourg 116
Nanjing 113
Los Angeles 111
New York 110
Lawrence 107
Roxbury 107
Boardman 97
Marseille 97
Rome 86
Dong Ket 84
Council Bluffs 80
Ho Chi Minh City 80
Brooklyn 71
Santa Clara 68
Des Moines 64
Munich 59
Princeton 58
Hanoi 56
São Paulo 52
London 47
Helsinki 44
San Diego 42
Jakarta 41
Dublin 37
Abidjan 35
Buffalo 35
Chicago 35
Columbus 34
Figino 33
Tokyo 33
Brussels 32
Jiaxing 32
North Bergen 32
Inglewood 31
Frankfurt am Main 30
Nanchang 29
Warsaw 29
Orem 28
Amsterdam 27
Moscow 27
Turin 27
Chennai 25
Rio de Janeiro 24
Falkenstein 23
Atlanta 22
Shenyang 22
Denver 21
Nuremberg 21
San Francisco 21
Paris 20
Redwood City 19
Tianjin 19
Montreal 18
Mumbai 18
Sannicandro di Bari 18
Guangzhou 17
Toronto 17
Changsha 16
Dearborn 16
West Jordan 16
Belo Horizonte 15
Hebei 15
Istanbul 15
Boston 14
Kansas City 14
Phoenix 14
Bologna 13
Johannesburg 13
Mexico City 13
Tashkent 13
Ankara 12
Brasília 12
Stockholm 12
Delhi 11
Leawood 11
Manchester 11
Medellín 11
Naples 11
Shanghai 11
Amman 10
Juiz de Fora 10
Redondo Beach 10
Totale 12.248
Salva come PNG Salva come JPEG
Nome #
1, 3‐Benzothiazoles as Antimicrobial Agents 1.126
1,2,3,4-Tetrahydroisoquinoline/2H-chromen-2-one conjugates as nanomolar P-glycoprotein inhibitors: Molecular determinants for affinity and selectivity over multidrug resistance associated protein 1 1.114
1,3-Benzothiazoles as Antimicrobial Agents 1.105
Probiotic and Tea Tree Oil Treatments Improve Therapy of Vaginal Candidiasis: A Preliminary Clinical Study 248
miRNAs for the Detection of MultiDrug Resistance: Overview and Perspectives 233
4H-1,4-benzothiazine, dihydro-1,4-benzothiazinones and 2-amino-5- fluorobenzenethiol derivatives: Design, synthesis and in vitro antimicrobial screening 218
2-Aminobenzothiazole derivatives: Search for new antifungal agents 210
Chasing ChEs-MAO B Multi-Targeting 4-Aminomethyl-7-Benzyloxy-2H-Chromen-2-ones 208
Investigating 1,2,3,4,5,6-hexahydroazepino[4,3-b]indole as scaffold of butyrylcholinesterase-selective inhibitors with additional neuroprotective activities for Alzheimer's disease 201
A convenient synthesis of lubeluzole and its enantiomer: Evaluation as chemosensitizing agents on human ovarian adenocarcinoma and lung carcinoma cells 183
Synthesis, in vitro evaluation, and molecular modeling investigation of benzenesulfonimide peroxisome proliferator-activated receptors α antagonists 183
Bioisosteric Modification of To042: Synthesis and Evaluation of Promising Use-Dependent Inhibitors of Voltage-Gated Sodium Channels 175
The chemosensitizing agent lubeluzole binds calmodulin and inhibits Ca2+/calmodulin-dependent Kinase II 174
Involvement of I2-imidazoline binding sites in positive and negative morphine analgesia modulatory effects 169
Effect of Methyl -β- Cyclodextrin on the antimicrobial activity of a new series of poorly water-soluble benzothiazoles 167
Beyond the Canonical Endocannabinoid System. A Screening of PPAR Ligands as FAAH Inhibitors 167
,3-Benzothiazoles as Antimicrobial Agents 165
Structure-property relationship study of the HPLC enantio-selective retention of neuroprotective 7-[(1-alkylpiperidin-3-yl)methoxy]coumarin derivatives on an amylose-based chiral stationary phase 165
In vitro interactions between anidulafungin and nonsteroidal anti-inflammatory drugs on biofilms of Candida spp 161
Structure-Activity Relationship Studies on Tetrahydroisoquinoline Derivatives: [4′-(6,7-Dimethoxy-3,4-dihydro-1H-isoquinolin-2-ylmethyl)biphenyl-4-ol] (MC70) Conjugated through Flexible Alkyl Chains with Furazan Moieties Gives Rise to Potent and Selective Ligands of P-glycoprotein 155
2-(2-Phenylcyclopropyl)-Imidazolines: Reversed Enantioselective Interaction At I1 and I2 Imidazoline Receptors 154
New tetrahydroisoquinoline-based P-glycoprotein modulators: Decoration of the biphenyl core gives selective ligands 154
1,3,5-triazine derivatives as dual inhibitors of 5-HT6R/FAAH in search of new therapy for Alzheimer's disease 153
Synthesis.and biological evaluation of pyridazino[4,3-b]indoles and indeno[1,2-c]pyridazines as new ligands of central and peripheral benzodiazepine receptors 148
Derivatives of Tenuazonic Acid as Potential New Multi-Target Anti-Alzheimer’s Disease Agents 146
Alpidem analogues containinig a GABA or glycine moiety as new anticonvulsant agents 144
Repositioning of Endonuclear Receptors Binders as Potential Antibacterial and Antifungal Agents. Eptyloxìm: A Potential and Novel Gyrase B and Cytochrome Cyp51 Inhibitor 142
Ligands of neuronal nicotinic acetylcholine receptor (nAChR): inferences from the Hansch and 3-D Quantitative Structure-Activity Relationship (QSAR) models 139
Structural Determinants in the Binding of BB2 Receptor Ligands: In Silico, X-Ray and NMR Studies in PD176252 Analogues. 138
High Affinity Central Benzodiazepine Receptor Ligands. Part 2: Quantitative Structure-Activity Relationships and Comparative Molecular Field Analysis of Pyrazolo[4,3-c]quinolin-3-ones 135
Lipophilicity of teicoplanin antibiotics as assessed by reversed phase high-performance liquid chromatography: quantitative structure-property and structure-activity relationships 135
Coumarin, chromone, and 4(3H)-pyrimidinone novel bicyclic and tricyclic derivatives as antiplatelet agents: synthesis, biological evaluation, and comparative molecular field analysis 131
Elucidation of the synergistic action of Mentha Piperita essential oil with common antimicrobials 131
A New Series of Aryloxyacetic Acids Endowed with Multi-Target Activity towards Peroxisome Proliferator-Activated Receptors (PPARs), Fatty Acid Amide Hydrolase (FAAH), and Acetylcholinesterase (AChE) 131
3D-QSAR models and docking studies of reversible inhibitors of type A and B Monoamine Oxidases 128
Investigation on platelet aggregation inhibitory activity by phenyl amides and esters of piperidinecarboxylic acids 126
The Versatile 2-Substituted Imidazoline Nucleus as a Structural Motif of Ligands Directed to the Serotonin 5-HT1A Receptor 126
(contributo in convegno) MOLECULAR DETERMINANTS FOR NUCLEAR RECEPTORS SELECTIVITY; CHEMOMETRIC ANALYSIS, DOCKINGS AND SITE-DIRECTED MUTAGENESIS OF DUAL PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS α/γ AGONISTS 122
Evaluation of water‐soluble Mannich base prodrugs of 2,3,4,5‐tetrahydroazepino[4,3‐b]indol‐1(6H)‐one as multitarget‐directed agents for Alzheimer’s disease 122
Ligand binding to I2 imidazoline receptor: the role of lipophilicity in quantitative structure-activity relationship models. 121
Allyphenyline Analogues Potentially Useful in the Management of Chronic Pain and Opioid Addiction 120
Understanding of the MAO-A and B Reversible Inhibitory Activity and Selectivity by Using 3D Descriptors of Lipophilicity 119
MOLECULAR DETERMINANTS FOR NUCLEAR RECEPTORS SELECTIVITY: CHEMOMETRIC ANALYSIS, DOCKINGS AND SITE-DIRECTED MUTAGENESIS OF DUAL PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS α/γ AGONISTS 119
Design, synthesis and biological evaluation of a class of bioisosteric oximes of the novel dual peroxisome proliferator-activated receptor alpha/gamma ligand LT175 119
Chiral pyrrolidines as multipotent agents in Alzheimer and neurodegenerative diseases 117
Guinea-pig ileum as ex vivo model useful to characterize ligands displaying Imidazoline I2 and Adrenergic alpha2 mixed activity: a preliminary study 116
The in silico insights of α-adrenergic receptors over the last decade: methodological approaches and structural features of the 3D models 116
2-D and 3-D modeling of imadazoline receptor ligands: insights into pharmacophore 116
Papain catalyzed hydrolysis of aryl esters: a comparison of the Hansch, Docking and CoMFA methods 115
Alpha2-adrenoreceptors profile modulation. 3.1 (R)-(+)-m-nitrobiphenyline, a new efficient and alpha2C-subtype selective agonist 115
Lubeluzole: from anti-ischemic to chemosensitizing agent 114
Neuronal Nicotinic Agonists: a Multi-approach Development of the Pharmacophore 113
alpha2-adrenoreceptors profile modulation and high antinociceptive activity of (S)-(-)-2-[1-(Biphenyl-2-yloxy)ethyl]-4,5-dihydro-1H-imidazole 113
Diffuse Intrinsic Pontine Glioma (DIPG): breakthrough and clinical perspective 113
Enhanced solubility and antibacterial activity of lipophilic fluoro-substituted N-benzoyl-2-aminobenzothiazoles by complexation with beta-cyclodextrins 112
Natural and synthetic geiparvarins are strong and selective MAO-B inhibitors. Synthesis and SAR studies. 110
Dioxane and oxathiane nuclei: suitable substructures for muscarinic agonists 110
Analisi conduttimetrica 109
Binding Models of Reversible Inhibitors to Monoamine Oxidases 108
Rational design of the new antihypertensive I1-receptor ligand 2-(2-biphenyl-2-yl-1-methyl-ethyl-)4,5-dihydro-1H-imidazole 108
Might the observed a2A-adrenoreceptor agonism or antagonism of allyphenyline analogues be ascribed to different molecular conformations? 106
High affinity central benzodiazepine receptor ligands: synthesis and structure-activity relationship studies of a new series of pyrazolo[4,3-c]quinolin-3-ones. 103
Exploring the Antibiofilm Effect of Sertraline in Synergy with Cinnamomum verum Essential Oil to Counteract Candida Species 102
A twenty-year journey exploring coumarin-based derivatives as bioactive molecules 102
Neuronal nicotinic receptor agonists: multi-approach pharmacophore development and 3D-QSAR predictive models, 102
High affinity central benzodiazepine receptor ligands II: QSAR studies and CoMFA analysis pyrazolo(4,3-c)quinolin-3-ones 101
Conformationally constrained butyrophenones with mixed dopaminergic (D(2)) and serotoninergic (5-HT(2A), 5-HT(2C)) affinities: synthesis, pharmacology, 3D-QSAR, and molecular modeling of (aminoalkyl)benzo- and -thienocycloalkanones as putative atypical antipsychotics. 99
Antifungal Biofilm Inhibitory Effects of Combinations of Diclofenac and Essential Oils 99
Rivastigmine structure-based hybrids as potential multi-target anti-Alzheimer’s drug candidates 99
Structure-based design of novel donepezil-like hybrids for a multi-target approach to the therapy of Alzheimer's disease 97
Novel Phenothiazine/Donepezil-Like Hybrids Endowed with Antioxidant Activity for a Multi-Target Approach to the Therapy of Alzheimer’s Disease 96
Binding models of reversible inhibitors to type-B monoamine oxidase 96
Pharmacophore development and 3D-QSAR study of I1 imidazoline binding site ligands 96
Design, Synthesis, Biological Evaluation, and Computational Studies of Novel Ureidopropanamides as Formyl Peptide Receptor 2 (FPR2) Agonists to Target the Resolution of Inflammation in Central Nervous System Disorders 96
alfa2-adrenoreceptors profile modulation. 2.1 Biphenyline analogues as tools for selective activation of alfa2C-subtype 95
Molecular determinants for nuclear receptors selectivity: chemometric analysis, dockings and site-directed mutagenesis of dual peroxisome proliferator-activated receptors alpha/gamma agonists 94
Enantiomeric Separation and Molecular Modelling of Bioactive 4-Aryl-3,4-dihydropyrimidin-2(1H)-one Ester Derivatives on Teicoplanin-Based Chiral Stationary Phase 94
Sintesi alternativa del lubeluzolo e del suo enantiomero e valutazione come agenti in grado di potenziare l'effetto di farmaci antitumorali. 92
2D- and 3D-QSAR of tocainide and mexiletine analogues acting as Na(v)1.4 channel blockers 92
Antibiofilm Effects of Plant Extracts Against Staphylococcus aureus 91
Linezolid hybrid analogs: synthesis and antimicrobial studies of oxalodinone-mercaptobenzothiazole compounds 91
Modeling the structural basis of the human CCR5 chemokine receptor functions: from homology model-builiding and molecular dynamics validation to agonist and anatgonist docking 90
Binding of tracizolines to the imidazoline receptor: the role of lipophilicity in quantitative structure-activity relationship models 89
Comparative Molecular Field Analysis of pyridawinone-containing alfa1-antagonists 88
Non-Antibiotic Drug Repositioning as an Alternative Antimicrobial Approach 87
Enhanced antibacterial efficacy of new benzothiazole phthalimide hybrid compounds/methyl--cyclodextrin inclusion complexes compared to the free forms: insights into the possible mode of action 87
Neuronal nicotinic receptor agonists: multi-approach pharmacophore development and 3D QSAR predictive models 86
Novel 6-alkyl-bridged 4-arylalkylpiperazin-1-yl derivatives of azepino[4,3-b]indol-1(2H)-one as potent BChE-selective inhibitors showing protective effects against neurodegenerative insults 84
New molecular requirements of Toc derivatives bearing a novel class of Nav1.4 blockers 83
Benzothiazole-Phthalimide Hybrids as Anti-Breast Cancer and Antimicrobial Agents 82
Recent Trends And Future Prospects In Computational GPCR Drug Discovery: From Virtual Screening To Polypharmacology. 82
Scouting around 1,2,3,4-Tetrahydrochromeno[3,2-c]pyridin-10-ones for Single- and Multitarget Ligands Directed towards Relevant Alzheimer's Targets 82
Dimeric analogs of the dual PPARα/γ agonist LT-175: design, synthesis and biological evaluation. 81
N‑Aryl-2,6-dimethylbenzamides, a new generation of tocainide analogues as blockers of skeletal muscle voltage-gated sodium channels 80
Multiple causes, multiple targets: FAAH as a centerpiece for therapy of multifactorial pathologies. 80
SAR of Non-Nucleoside HIV-1 RT inhibitors (NNRTIs): Comparative Molecular field Analysis (CoMFA) and Docking Studies 78
Evaluation of the Potential Cytoprotective Effect of Melatonin in Comparison with Vitamin E and Trolox against Cd2+-Induced Toxicity in SH-SY5Y, HCT 116, and HepG2 Cell Lines 77
Extended form of a retro-inverso peptide stabilized by beta-sheet unidirectional H-bonds: Crystallographic and NMR evidence 77
Multi-Target Approach for the Design of New Compounds Potentially Useful for the Prevention and Treatment of Cardiovascular and/or Neurodegenerative Diseases 77
DESIGN, SYNTHESIS AND BIOLOGICAL EVALUATION OF NEW ANALOGS OF THE DUAL PPARα/γ AGONIST LT175. 75
Totale 15.143
Salva come PNG Salva come JPEG
Categoria #
all - tutte 65.072
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 65.072
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022851 43 105 11 41 22 48 49 44 56 84 134 214
2022/20231.556 220 141 93 125 183 190 14 155 337 22 40 36
2023/2024675 44 99 26 43 52 102 40 29 39 54 52 95
2024/20252.436 73 69 196 109 66 165 221 233 148 145 356 655
2025/20267.950 698 773 2.169 677 565 352 583 213 535 542 215 628
2026/2027120 120 0 0 0 0 0 0 0 0 0 0 0
Totale 18.241